Reference health
Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL‐10
37/37 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 37 checked references that resolve
resolves10.4049/jimmunol.141.3.1047
Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
resolves10.1016/0008-8749(89)90209-8
Distinct immunologic specificity of tumor regression mediated by effector cells isolated from immunized and tumor-bearing mice
resolves10.1097/00002371-199304000-00002
Generation of T-Cells Reactive to the Poorly Immunogenic B16-BL6 Melanoma with Efficacy in the Treatment of Spontaneous Metastases
resolves10.4049/jimmunol.175.3.1424
Simultaneous Targeting of CD3 on T Cells and CD40 on B or Dendritic Cells Augments the Antitumor Reactivity of Tumor-Primed Lymph Node Cells
resolves10.1158/0008-5472.CAN-07-5530
Interleukin-21 Augments the Efficacy of T-Cell Therapy by Eliciting Concurrent Cellular and Humoral Responses
resolves10.4049/jimmunol.0803773
In Vivo Sensitized and In Vitro Activated B Cells Mediate Tumor Regression in Cancer Adoptive Immunotherapy
resolves10.1158/1078-0432.CCR-11-0207
Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression
resolves10.1097/00002371-200407000-00003
Enhanced Efficacy of Melanoma Vaccines in the Absence of B Lymphocytes
resolves10.1002/ijc.21177
Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti-tumor CTL and TH1 cytokine responses by B cells
resolves10.4049/jimmunol.164.2.688
Resting B Lymphocytes as APC for Naive T Lymphocytes: Dependence on CD40 Ligand/CD40
resolves10.1016/S1074-7613(02)00274-1
Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation
resolves10.1073/pnas.1100994108
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis
resolves10.4049/jimmunol.0900270
The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals
resolves10.1111/j.1749-6632.2009.05137.x
B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer
resolves10.4049/jimmunol.178.12.7868
Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis
resolves10.1016/j.immuni.2008.03.017
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
resolves10.4049/jimmunol.1203364
Constitutively CD40–Activated B Cells Regulate CD8 T Cell Inflammatory Response by IL-10 Induction
resolves10.4049/jimmunol.0803052
Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/
<i>lpr</i>
Mice
resolves10.4049/jimmunol.1300649
Peritoneal Cavity Regulatory B Cells (B10 Cells) Modulate IFN-γ+CD4+ T Cell Numbers during Colitis Development in Mice
resolves10.4049/jimmunol.159.2.664
Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role
resolves10.4049/jimmunol.167.2.1081
Lipopolysaccharide-Activated B Cells Down-Regulate Th1 Immunity and Prevent Autoimmune Diabetes in Nonobese Diabetic Mice
resolves10.1371/journal.pone.0070131
Interleukin-5 Supports the Expansion of Fas Ligand-Expressing Killer B Cells that Induce Antigen-Specific Apoptosis of CD4+ T Cells and Secrete Interleukin-10
resolves10.1006/cimm.1995.1017
The Antitumor Activity Induced by the in Vivo Administration of Activated B Cells Bound to Anti-CD3 Monoclonal Antibody
resolves10.1038/srep00765
12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?
resolves10.1158/0008-5472.CAN-14-0249
Enhancement of the T-cell Armamentarium as a Cell-Based Therapy for Prostate Cancer
resolves10.1158/0008-5472.CAN-03-2799
Donor Cell Cycling, Trafficking, and Accumulation during Adoptive Immunotherapy for Murine Lung Metastases
The 2 references without a DOI — listed, not checked
no DOI — not checkedCD40‐stimulated B lymphocytes pulsed with tumor antigens are effective antigen‐presenting cells that can generate specific T cells
no DOI — not checkedRegulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/eji.201444625"><img src="https://citestamp.com/citestamped/10.1002/eji.201444625/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/eji.201444625)